Literature DB >> 24360826

Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain.

Hajime Seki1, Sabine Pellett2, Peter Silhár1, G Neil Stowe1, Beatriz Blanco3, Matthew A Lardy1, Eric A Johnson2, Kim D Janda4.   

Abstract

Botulinum neurotoxin A (BoNT/A) is the most potent toxin known. Unfortunately, it is also a potential bioweapon in terrorism, which is without an approved therapeutic treatment once cellular intoxication takes place. Previously, we reported how hydroxamic acid prodrug carbamates increased cellular uptake, which translated to successful inhibition of this neurotoxin. Building upon this research, we detail BoNT/A protease molecular modeling studies accompanied by the construction of small library of hydroxamic acids based on 2,4-dichlorocinnamic hydroxamic acid scaffold and their carbamate prodrug derivatization along with the evaluation of these molecules in both enzymatic and cellular models.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Botulinum neurotoxin; Carbamate prodrug; Hydroxamic acid; Protease inhibitor; SNAP-25; SNARE; Zinc-dependent metalloprotease

Mesh:

Substances:

Year:  2013        PMID: 24360826      PMCID: PMC3919520          DOI: 10.1016/j.bmc.2013.11.053

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  30 in total

1.  Improved solution- and solid-phase preparation of hydroxamic acids from esters.

Authors:  Chih Y Ho; Eric Strobel; Janet Ralbovsky; Robert A Galemmo
Journal:  J Org Chem       Date:  2005-06-10       Impact factor: 4.354

2.  Identification of a potent botulinum neurotoxin a protease inhibitor using in situ lead identification chemistry.

Authors:  Grant E Boldt; Jack P Kennedy; Kim D Janda
Journal:  Org Lett       Date:  2006-04-13       Impact factor: 6.005

3.  Targeting botulinum A cellular toxicity: a prodrug approach.

Authors:  Peter Silhár; Lisa M Eubanks; Hajime Seki; Sabine Pellett; Sacha Javor; William H Tepp; Eric A Johnson; Kim D Janda
Journal:  J Med Chem       Date:  2013-10-15       Impact factor: 7.446

4.  Carbamate prodrug concept for hydroxamate HDAC inhibitors.

Authors:  Sonja Schlimme; Alexander-Thomas Hauser; Vincenzo Carafa; Ralf Heinke; Srinivasaraghavan Kannan; Diana A Stolfa; Saverio Cellamare; Angelo Carotti; Lucia Altucci; Manfred Jung; Wolfgang Sippl
Journal:  ChemMedChem       Date:  2011-03-17       Impact factor: 3.466

5.  Lipophilic Isosteres of a π-π Stacking Interaction: New Inhibitors of the Bcl-2-Bak Protein-Protein Interaction.

Authors:  Naeem Yusuff; Michaël Doré; Carol Joud; Michael Visser; Clayton Springer; Xiaoling Xie; Kara Herlihy; Dale Porter; B Barry Touré
Journal:  ACS Med Chem Lett       Date:  2012-05-27       Impact factor: 4.345

Review 6.  Bacterial toxins: a table of lethal amounts.

Authors:  D M Gill
Journal:  Microbiol Rev       Date:  1982-03

7.  Carbonyldiimidazole-mediated Lossen rearrangement.

Authors:  Pascal Dubé; Noah F Fine Nathel; Michael Vetelino; Michel Couturier; Claude Larrivée Aboussafy; Simon Pichette; Matthew L Jorgensen; Mark Hardink
Journal:  Org Lett       Date:  2009-12-17       Impact factor: 6.005

8.  Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibility.

Authors:  Nicholas R Silvaggi; Grant E Boldt; Mark S Hixon; Jack P Kennedy; Saul Tzipori; Kim D Janda; Karen N Allen
Journal:  Chem Biol       Date:  2007-05

Review 9.  The evolving field of biodefence: therapeutic developments and diagnostics.

Authors:  James C Burnett; Erik A Henchal; Alan L Schmaljohn; Sina Bavari
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

10.  A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformation than SNAP-25 substrate.

Authors:  Jorge E Zuniga; James J Schmidt; Timothy Fenn; James C Burnett; Demet Araç; Rick Gussio; Robert G Stafford; Shirin S Badie; Sina Bavari; Axel T Brunger
Journal:  Structure       Date:  2008-10-08       Impact factor: 5.006

View more
  6 in total

1.  Catch and Anchor Approach To Combat Both Toxicity and Longevity of Botulinum Toxin A.

Authors:  Lucy Lin; Margaret E Olson; Takashi Sugane; Lewis D Turner; Margarita A Tararina; Alexander L Nielsen; Elbek K Kurbanov; Sabine Pellett; Eric A Johnson; Seth M Cohen; Karen N Allen; Kim D Janda
Journal:  J Med Chem       Date:  2020-09-18       Impact factor: 7.446

2.  Identification of Slow-Binding Inhibitors of the BoNT/A Protease.

Authors:  Ealin N Patel; Lewis D Turner; Mark S Hixon; Kim D Janda
Journal:  ACS Med Chem Lett       Date:  2022-03-08       Impact factor: 4.632

3.  A platform stratifying a sequestering agent and a pharmacological antagonist as a means to negate botulinum neurotoxicity.

Authors:  Tyler L Harris; Colin A Lowery; Mark S Hixon; Kim D Janda
Journal:  ACS Chem Neurosci       Date:  2014-07-11       Impact factor: 4.418

4.  Cellular Protection of SNAP-25 against Botulinum Neurotoxin/A: Inhibition of Thioredoxin Reductase through a Suicide Substrate Mechanism.

Authors:  Hajime Seki; Song Xue; Sabine Pellett; Peter Šilhár; Eric A Johnson; Kim D Janda
Journal:  J Am Chem Soc       Date:  2016-04-20       Impact factor: 15.419

5.  Probing BoNT/A protease exosites: implications for inhibitor design and light chain longevity.

Authors:  Song Xue; Sacha Javor; Mark S Hixon; Kim D Janda
Journal:  Biochemistry       Date:  2014-10-21       Impact factor: 3.162

6.  Carbamates as Potential Prodrugs and a New Warhead for HDAC Inhibition.

Authors:  Kristina King; Alexander-Thomas Hauser; Jelena Melesina; Wolfgang Sippl; Manfred Jung
Journal:  Molecules       Date:  2018-02-02       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.